Universal screening of Tanzanian HIV-infected adult inpatients with the serum cryptococcal antigen to improve diagnosis and reduce mortality: An operational study

Journal of the International AIDS Society

Volumn 14, Issue 1, 2011, Pages

  Wajanga, Bahati Mk ^a,b   Kalluvya, Samuel ^a,b   Downs, Jennifer A ^a,b,c   Johnson, Warren D ^c   Fitzgerald, Daniel W ^c   Peck, Robert N ^a,b,c  

^a Bugando Medical Centre   (Tanzania)

^b CATHOLIC UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE; FUNGUS ANTIGEN; ANTIFUNGAL AGENT;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CRYPTOCOCCAL MENINGITIS; CRYPTOCOCCUS; DISEASE ASSOCIATION; FEMALE; FEVER; HEADACHE; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MENTAL HEALTH; MORTALITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; TANZANIA; ADOLESCENT; BLOOD; CEREBROSPINAL FLUID; CHEMISTRY; HOSPITAL; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MIDDLE AGED; SURVIVAL;

ADOLESCENT; ADULT; ANTIFUNGAL AGENTS; ANTIGENS, FUNGAL; CEREBROSPINAL FLUID; COHORT STUDIES; CRYPTOCOCCUS; FEMALE; HIV INFECTIONS; HOSPITALS; HUMANS; INPATIENTS; MALE; MASS SCREENING; MENINGITIS, CRYPTOCOCCAL; MICROBIOLOGICAL TECHNIQUES; MIDDLE AGED; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TANZANIA; YOUNG ADULT;

EID: 80053631425     PISSN: None     EISSN: 17582652     Source Type: Journal    
DOI: 10.1186/1758-2652-14-48     Document Type: Article

References (29)

1. Review of human immunodeficiency virus type 1-related opportunistic infections in sub-Saharan Africa. Holmes CB, Losina E, Walensky RP, Yazdanpanah Y, Freedberg KA, Clin Infect Dis 2003 36 5 652 662 10.1086/367655 12594648 (Pubitemid 36259573)
2. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. Park BJ, Wannemuehler KA, Marston BJ, Govender N, Pappas PG, Chiller TM, AIDS 2009 23 4 525 530 10.1097/QAD.0b013e328322ffac 19182676
3. Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults. French N, Gray K, Watera C, Nakiyingi J, Lugada E, Moore M, Lalloo D, Whitworth JA, Gilks CF, AIDS 2002 16 7 1031 1038 10.1097/00002030-200205030-00009 11953469 (Pubitemid 34499426)
4. Causes of death in a rural, population-based human immunodeficiency virus type 1 (HIV-1) natural history cohort in Uganda. Okongo M, Morgan D, Mayanja B, Ross A, Whitworth J, Int J Epidemiol 1998 27 4 698 702 10.1093/ije/27.4.698 9758128 (Pubitemid 28431516)
5. Factors associated with an increased case-fatality rate in HIV-infected and non-infected South African gold miners with pulmonary tuberculosis. Churchyard GJ, Kleinschmidt I, Corbett EL, Murray J, Smit J, De Cock KM, Int J Tuberc Lung Dis 2000 4 8 705 712 10949321 (Pubitemid 30650029)
6. High ongoing burden of cryptococcal disease in Africa despite antiretroviral roll out. Jarvis JN, Boulle A, Loyse A, Bicanic T, Rebe K, Williams A, Harrison TS, Meintjes G, AIDS 2009 23 9 1182 1183 10.1097/QAD.0b013e32832be0fc 19451796
7. Cryptococcal meningitis in Rio de Janeiro State, Brazil, 1994-2004. Leimann BC, Koifman RJ, Cad Saude Publica 2008 24 11 2582 2592 10.1590/S0102-311X2008001100013 19009138
8. Treatment of cryptococcal meningitis in resource limited settings. Sloan DJ, Dedicoat MJ, Lalloo DG, Curr Opin Infect Dis 2009 22 5 455 463 10.1097/QCO.0b013e32832fa214 19587589
9. Treatment of acute cryptococcal meningitis in HIV infected adults, with an emphasis on resource-limited settings. Sloan D, Dlamini S, Paul N, Dedicoat M, Cochrane Database Syst Rev 2008 4 D005647
10. Dose response effect of high-dose fluconazole for HIV-associated cryptococcal meningitis in southwestern Uganda. Longley N, Muzoora C, Taseera K, Mwesigye J, Rwebembera J, Chakera A, Wall E, Andia I, Jaffar S, Harrison TS, Clin Infect Dis 2008 47 12 1556 1561 10.1086/593194 18990067
11. Fungal burden, early fungicidal activity, and outcome in cryptococcal meningitis in antiretroviral-naive or antiretroviral-experienced patients treated with amphotericin B or fluconazole. Bicanic T, Meintjes G, Wood R, Hayes M, Rebe K, Bekker LG, Harrison T, Clin Infect Dis 2007 45 1 76 80 10.1086/518607 17554704 (Pubitemid 46984619)
12. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america. Perfect JR, Dismukes WE, Dromer F, Goldman DL, Graybill JR, Hamill RJ, Harrison TS, Larsen RA, Lortholary O, Nguyen MH, et al. Clin Infect Dis 2010 50 3 291 322 10.1086/649858 20047480
13. Screening for cryptococcal antigenemia in patients accessing an antiretroviral treatment program in South Africa. Jarvis JN, Lawn SD, Vogt M, Bangani N, Wood R, Harrison TS, Clin Infect Dis 2009 48 7 856 862 10.1086/597262 19222372
14. Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count < or = 100 cells/microL who start HIV therapy in resource-limited settings. Meya DB, Manabe YC, Castelnuovo B, Cook BA, Elbireer AM, Kambugu A, Kamya MR, Bohjanen PR, Boulware DR, Clin Infect Dis 2010 51 4 448 455 10.1086/655143 20597693
15. Antiretroviral Therapy for HIV Infection in Adults and Adolescents: a Public Health Approach. World Health Organization, WHO 2010 http://www.who.int/ hiv/pub/arv/adult2010/en/index.html
16. National Guidelines for Clinical Management of HIV/AIDS. Tanzanian Ministry of Health, TMoH 2009 http://collections.infocollections.org/whocountry/ en/d/Js6885e
17. TB/HIV: A Clinical Manual. World Health Organization, WHO 2004 http://www.who.int/child-adolescent-health/documents/9241546344/en/index.html
18. Comparison of commercial kits for detection of cryptococcal antigen. Tanner DC, Weinstein MP, Fedorciw B, Joho KL, Thorpe JJ, Reller L, J Clin Microbiol 1994 32 7 1680 1684 7929757 (Pubitemid 24189556)
19. Low CD4 count plus coma predicts cryptococcal meningitis in Tanzania. Kisenge PR, Hawkins AT, Maro VP, McHele JP, Swai NS, Mueller A, Houpt ER, BMC Infect Dis 2007 7 39 10.1186/1471-2334-7-39 17493266 (Pubitemid 46851568)
20. AIDS-associated cryptococcal meningitis in Rwanda (1983-1992): epidemiologic and diagnostic features. Bogaerts J, Rouvroy D, Taelman H, Kagame A, Aziz MA, Swinne D, Verhaegen J, J Infect 1999 39 1 32 37 10.1016/S0163- 4453(99)90099-3 10468126 (Pubitemid 29396603)
21. Cryptococcal meningitis. Bicanic T, Harrison TS, Br Med Bull 2004 72 99 118 15838017 (Pubitemid 40712661)
22. Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis. The NIAID Mycoses Study Group and AIDS Cooperative Treatment Groups. Graybill JR, Sobel J, Saag M, van Der Horst C, Powderly W, Cloud G, Riser L, Hamill R, Dismukes W, Clin Infect Dis 2000 30 1 47 54 10.1086/313603 10619732 (Pubitemid 30067061)
23. Relationship of cerebrospinal fluid pressure, fungal burden and outcome in patients with cryptococcal meningitis undergoing serial lumbar punctures. Bicanic T, Brouwer AE, Meintjes G, Rebe K, Limmathurotsakul D, Chierakul W, Teparrakkul P, Loyse A, White NJ, Wood R, et al. AIDS 2009 23 6 701 706 19279443
24. Late-disease stage at presentation to an HIV clinic in the era of free antiretroviral therapy in Sub-Saharan Africa. Kigozi IM, Dobkin LM, Martin JN, Geng EH, Muyindike W, Emenyonu NI, Bangsberg DR, Hahn JA, J Acquir Immune Defic Syndr 2009 52 2 280 289 10.1097/QAI.0b013e3181ab6eab 19521248
25. Strategies to reduce early morbidity and mortality in adults receiving antiretroviral therapy in resource-limited settings. Lawn SD, Harries AD, Wood R, Curr Opin HIV AIDS 2010 5 1 18 26 10.1097/COH.0b013e328333850f 20046144
26. Prevalence, determinants of positivity, and clinical utility of cryptococcal antigenemia in Cambodian HIV-infected patients. Micol R, Lortholary O, Sar B, Laureillard D, Ngeth C, Dousset JP, Chanroeun H, Ferradini L, Guerin PJ, Dromer F, et al. J Acquir Immune Defic Syndr 2007 45 5 555 559 10.1097/QAI.0b013e31811ed32c 17577124 (Pubitemid 47294928)
27. Asymptomatic serum cryptococcal antigenemia and early mortality during antiretroviral therapy in rural Uganda. Liechty CA, Solberg P, Were W, Ekwaru JP, Ransom RL, Weidle PJ, Downing R, Coutinho A, Mermin J, Trop Med Int Health 2007 12 8 929 935 10.1111/j.1365-3156.2007.01874.x 17697087 (Pubitemid 47245826)
28. Cost-effectiveness of primary prophylaxis of AIDS associated cryptococcosis in Cambodia. Micol R, Tajahmady A, Lortholary O, Balkan S, Quillet C, Dousset JP, Chanroeun H, Madec Y, Fontanet A, Yazdanpanah Y, PLoS One 2010 5 11 13856 10.1371/journal.pone.0013856 21085478
29. Cryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: proposed clinical case definitions. Haddow LJ, Colebunders R, Meintjes G, Lawn SD, Elliott JH, Manabe YC, Bohjanen PR, Sungkanuparph S, Easterbrook PJ, French MA, et al. Lancet Infect Dis 2010 10 11 791 802 10.1016/S1473-3099(10)70170-5 21029993